Summit Therapeutics Inc.
SMMT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001599298
No open-market purchases or sales by Summit Therapeutics Inc. insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q2 2026, worth $1.98B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Summit Therapeutics Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 54 | 51 | −3 |
| Shares | 11.0M | 11.0M | −30.9K (−0.3%) |
| Value | $82.4M | $55.3M | −$27.1M (−32.9%) |
New holders (4)
Institutions that held Summit Therapeutics Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Russell Investments Group, Ltd. | 87,413 | $437.0K | 0.00% |
| SG Americas Securities, LLC | 23,200 | $116.0K | 0.00% |
| Inscription Capital, LLC | 17,000 | $85.0K | 0.03% |
| Susquehanna International Group, LLP | 12,820 | $64.0K | 0.00% |
Sold out (7)
Institutions that held Summit Therapeutics Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Renaissance Technologies LLC | 125,452 | $936.0K |
| FIL Ltd | 104,100 | $777.0K |
| Citadel Advisors LLC | 25,618 | $191.0K |
| STRS Ohio | 5,200 | $38.0K |
| Steward Partners Investment Advisory, LLC | 2,000 | $15.0K |
| Riverview Trust Co | 1,000 | $7.00K |
| Group One Trading, L.P. | 100 | $1.00K |